GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cantourage Group SE (XTER:HIGH) » Definitions » ROE % Adjusted to Book Value

Cantourage Group SE (XTER:HIGH) ROE % Adjusted to Book Value : 0.00% (As of Jun. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Cantourage Group SE ROE % Adjusted to Book Value?

Cantourage Group SE's ROE % for the quarter that ended in Jun. 2023 was 0.06%. Cantourage Group SE's PB Ratio for the quarter that ended in Jun. 2023 was N/A. Cantourage Group SE's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2023 was N/A.


Cantourage Group SE ROE % Adjusted to Book Value Historical Data

The historical data trend for Cantourage Group SE's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cantourage Group SE ROE % Adjusted to Book Value Chart

Cantourage Group SE Annual Data
Trend Dec19 Dec20 Dec21 Dec22
ROE % Adjusted to Book Value
- - - -

Cantourage Group SE Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23
ROE % Adjusted to Book Value Get a 7-Day Free Trial - - - - -

Competitive Comparison of Cantourage Group SE's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Cantourage Group SE's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cantourage Group SE's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cantourage Group SE's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Cantourage Group SE's ROE % Adjusted to Book Value falls into.



Cantourage Group SE ROE % Adjusted to Book Value Calculation

Cantourage Group SE's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2022 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.04% / N/A
=N/A

Cantourage Group SE's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.06% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cantourage Group SE ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Cantourage Group SE's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Cantourage Group SE (XTER:HIGH) Business Description

Comparable Companies
Traded in Other Exchanges
Address
Feurigstrasse 54, Berlin, DEU, 10827
Cantourage Group SE is a medical cannabis company. The company offers products in all relevant market segments: dried flowers, extracts, Dronabinol, and pharma-grade Cannabidiol.
Executives
Patrick Hoffmann Supervisory Board
Dr. Florian Kainzinger Supervisory Board
Dr. / Dr. Florian / Michael Kainzinger / Ruoff Supervisory Board
Dr. / Dr. Florian /michael Kainzinger / Ruoff Supervisory Board
Dr. / Herr Florian / Patrick Holzapfel / Hoffmann Supervisory Board
Dr. Florian Holzapfel Supervisory Board
Dr. Michael Ruoff Supervisory Board

Cantourage Group SE (XTER:HIGH) Headlines